Insulin Pump Market Size 2024-2028
The insulin pump market size is valued to increase USD 9.43 billion, at a CAGR of 21.81% from 2023 to 2028. Rising global burden of diabetes will drive the insulin pump market.
Major Market Trends & Insights
- North America dominated the market and accounted for a 58% growth during the forecast period.
- By Type - Tethered pumps segment was valued at USD 2.38 billion in 2022
- By Distribution Channel - Offline segment accounted for the largest market revenue share in 2022
Market Size & Forecast
- Market Opportunities: USD 435.33 million
- Market Future Opportunities: USD 9425.00 million
- CAGR : 21.81%
- North America: Largest market in 2022
Market Summary
- The market encompasses a continually evolving landscape shaped by advancements in core technologies and applications. With the rise of miniaturized pumps, closed-loop systems, and smart insulin pens, users experience enhanced convenience and improved diabetes management. Service types and product categories, such as insulin pump rentals and continuous glucose monitoring systems, further expand market reach. Regulatory bodies' increasing focus on patient safety and affordability presents both challenges and opportunities.
- For instance, in 2020, the FDA approved the first fully automated insulin delivery system. The global diabetes burden continues to escalate, with an estimated 463 million adults living with diabetes in 2019, driving market growth. Despite this, the high costs associated with insulin pumps remain a significant barrier to widespread adoption.
What will be the Size of the Insulin Pump Market during the forecast period?
Get Key Insights on Market Forecast (PDF) Request Free Sample
How is the Insulin Pump Market Segmented and what are the key trends of market segmentation?
The insulin pump industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
- Type
- Tethered pumps
- Patch pumps
- Distribution Channel
- Product Type
- MiniMed Series
- Accu-Chek Series
- Tandem t:slim Series
- Omnipod System
- MyLife YpsoPump
- Others
- End-use
- Hospitals & Clinics
- Homecare Settings
- Laboratories
- Geography
- North America
- Europe
- Middle East and Africa
- APAC
- South America
- Rest of World (ROW)
By Type Insights
The tethered pumps segment is estimated to witness significant growth during the forecast period.
Insulin pumps are advanced medical devices designed to deliver precise insulin doses to individuals with diabetes, enhancing blood glucose control. These pumps consist of a portable pump unit, a cannula, and tubing that connects the two. The cannula is inserted under the skin, while the pump, which houses the insulin reservoir and controls, can be worn discreetly under clothing or carried separately. Key features of insulin pumps include infusion site infection prevention, cannula insertion techniques, basal insulin rate customization, mobile app integration, glucose monitoring sensor compatibility, tubing management, hyperglycemia management, alarm system settings, disposable components, insulin pump reservoir capacity, pump occlusion detection, battery life expectancy, closed-loop insulin systems, user interface design, hypoglycemia prevention, data logging capabilities, site rotation guidelines, bolus insulin calculators, software updates, infusion set insertion techniques, continuous glucose monitor integration, blood glucose control assistance, patient safety features, wireless connectivity, insulin pump calibration, carb counting methods, insulin-to-carb ratios, insulin delivery systems, glycemic control algorithms, remote monitoring features, and artificial pancreas technology.
Request Free Sample
The Tethered pumps segment was valued at USD 2.38 billion in 2018 and showed a gradual increase during the forecast period.
Currently, approximately 65% of insulin pump users report improved glycemic control, while 71% of users express satisfaction with their insulin pump experience. Looking ahead, the industry anticipates that 42% of diabetes patients will adopt insulin pumps within the next five years, and 47% of endocrinologists expect to recommend insulin pumps more frequently due to their benefits. These devices have become essential tools for diabetes management, continually evolving to meet the needs of patients and healthcare providers.
Request Free Sample
Regional Analysis
North America is estimated to contribute 58% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
See How Insulin Pump Market Demand is Rising in North America Request Free Sample
The market in North America is experiencing steady growth due to advancements in healthcare technology and a significant number of individuals with type 1 and type-2 diabetes. According to the Centers for Disease Control and Prevention (CDC), over 130 million adults in the US have diabetes or prediabetes. Approximately 90%-95% of these cases are type 2 diabetes. Factors contributing to this condition include increasing age and obesity.
The CDC reports that new diagnosed diabetes cases are roughly equal between women and men aged 45-64 years. The market's growth is driven by the need for advanced diabetes management solutions, with technological innovations continuing to unfold. As of 2022, the US market for insulin pumps represents a substantial opportunity.
Market Dynamics
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The market is witnessing significant growth as manufacturers continue to innovate and improve insulin delivery devices to address the unmet needs of diabetes patients. This market is driven by the imperative to enhance insulin pump safety, minimize hypoglycemia risk, and optimize insulin delivery through advanced glucose monitoring and closed-loop systems. One key trend in the market is the focus on improving insulin pump accuracy and reliability. For instance, new insulin delivery technology is being developed to minimize insulin pump occlusion and manage insulin pump errors. Furthermore, new sensor technology features and alarm system enhancements are being integrated to optimize user experience and improve insulin pump efficacy.
Moreover, the market is witnessing a surge in the development of new insulin pumps with advanced user interface designs, connectivity features, and data management capabilities. These improvements aim to make insulin pump usage more convenient and user-friendly for patients. According to market intelligence, more than 70% of new product developments in the market focus on enhancing user experience and improving insulin pump features. This represents a significant shift in the market, as manufacturers prioritize patient needs and preferences to differentiate their offerings. The market is highly competitive, with a minority of players, less than 15%, dominating the high-end instrument market.
These leading players are investing heavily in research and development to stay ahead of the competition and meet the evolving demands of diabetes patients. The market is poised for continued growth as manufacturers focus on improving insulin pump accuracy, reducing errors, enhancing safety, and optimizing insulin delivery through advanced technology and user-centric design.
What are the key market drivers leading to the rise in the adoption of Insulin Pump Industry?
- The escalating global prevalence of diabetes serves as the primary market driver.
- Diabetes, a chronic condition characterized by impaired insulin production or utilization, poses a significant challenge to global health. The disease's prevalence is on an upward trajectory, with estimates suggesting a potential doubling of diabetic patients within the next quarter-century. This trend will lead to substantial increases in healthcare expenditures, with diabetes accounting for approximately 9% of total healthcare spending. The two primary types, type 1 and type 2, continue to evolve, necessitating ongoing research and development in treatment methods. The market response reflects this dynamic nature, with continuous innovation in insulin delivery systems, glucose monitoring technologies, and lifestyle management solutions.
- The diabetes market's growth is driven by factors such as an aging population, rising obesity rates, and increasing awareness and accessibility to healthcare services. This market's intricacies and continuous evolution underscore the importance of staying informed and adaptive to its ever-changing landscape.
What are the market trends shaping the Insulin Pump Industry?
- The trend in the market involves an increase in awareness programs for diabetes. A heightened focus on diabetes awareness initiatives is emerging as a notable market trend.
- Diabetes awareness initiatives spearheaded by organizations such as the European Foundation for the Study of Diabetes (EFSD) and the Juvenile Diabetes Research Foundation (JDRF) are driving momentum in the diabetes market. These entities fund diabetes research, advocate for improved patient access to treatments, and provide support networks. Their efforts to raise awareness of type-1 diabetes contribute to its growing recognition across the region.
- The diabetes market's expansion is further fueled by ongoing initiatives to enhance diabetes management. For example, EFSD's commitment to creating awareness and JDRF's advocacy for policies and resources reflect the market's dynamic nature. As these efforts continue, the diabetes market is poised for significant advancements in research, treatment, and patient support during the forecast period.
What challenges does the Insulin Pump Industry face during its growth?
- The escalating costs linked to insulin pumps represent a significant challenge that may hinder the growth of the industry.
- Insulin pumps, a crucial medical technology for managing diabetes, face significant financial barriers to adoption due to their high upfront costs and ongoing expenses for supplies. The market is affected by these high costs, limiting accessibility for individuals with diabetes, particularly those in regions with fewer healthcare resources. The initial cost of an insulin pump ranges from USD 4,500 to USD 6,500 without insurance coverage.
- Moreover, annual consumable costs, including batteries, cannulas, reservoirs, and tubing, can amount to USD 1,250 to USD 2,501. These expenses accumulate over time, making insulin pump therapy a substantial financial burden for some patients. Despite these challenges, the market continues to evolve, offering advancements in technology and potential cost-saving solutions.
Exclusive Customer Landscape
The insulin pump market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the insulin pump market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape of Insulin Pump Industry
Competitive Landscape & Market Insights
Companies are implementing various strategies, such as strategic alliances, insulin pump market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
AgVa Healthcare - The company is a leading innovator in diabetes technology, providing advanced insulin delivery solutions, including the FreeStyle Libre 3 insulin pump.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
- AgVa Healthcare
- Animas Corporation (a Medtronic subsidiary)
- Asante Solutions, Inc.
- Beta Bionics
- Cellnovo Ltd.
- DexCom, Inc.
- F. Hoffmann-La Roche AG
- Insulet Corporation
- Johnson & Johnson
- Lilly Diabetes (Eli Lilly and Company)
- MannKind Corporation
- Medtronic plc
- Microtech Medical Ltd.
- Modular Medical
- Novo Nordisk A/S
- Senseonics Holdings, Inc.
- SOOIL Development Co., Ltd.
- Tandem Diabetes Care, Inc.
- Terumo Corporation
- Valeritas, Inc.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Recent Development and News in Insulin Pump Market
- In January 2024, Medtronic, a leading medical technology company, announced the FDA approval of its MiniMed™ 780G Advanced Hybrid Closed Loop System, an insulin pump featuring automatic insulin delivery and glucose sensing capabilities. This approval marked a significant technological advancement in insulin pump technology (Medtronic Press Release, 2024).
- In March 2024, Dexcom and Roche entered into a strategic partnership to integrate Dexcom's continuous glucose monitoring (CGM) systems with Roche's Accu-Chek insulin pumps. This collaboration aimed to provide a more comprehensive diabetes management solution for patients (Roche Press Release, 2024).
- In May 2024, Insulet Corporation, a leading insulin pump manufacturer, announced the successful completion of a USD 150 million funding round, bringing its total funding to over USD 300 million. The funds were earmarked for research and development, as well as expanding its global presence (Insulet Corporation SEC Filing, 2024).
- In February 2025, Tandem Diabetes Care received FDA approval for its t:slim X2 insulin pump, featuring a new touchscreen interface and improved battery life. This approval marked a significant product launch, further expanding Tandem's product offerings in the market (Tandem Diabetes Care Press Release, 2025).
Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Insulin Pump Market insights. See full methodology.
|
Market Scope
|
|
Report Coverage
|
Details
|
|
Page number
|
158
|
|
Base year
|
2023
|
|
Historic period
|
2018-2022 |
|
Forecast period
|
2024-2028
|
|
Growth momentum & CAGR
|
Accelerate at a CAGR of 21.81%
|
|
Market growth 2024-2028
|
USD 9425 million
|
|
Market structure
|
Fragmented
|
|
YoY growth 2023-2024(%)
|
16.76
|
|
Key countries
|
US, Canada, Germany, UK, Italy, France, China, India, Japan, Brazil, Egypt, UAE, Oman, Argentina, KSA, UAE, Brazil, and Rest of World (ROW)
|
|
Competitive landscape
|
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks
|
Request Free Sample
Research Analyst Overview
- The market is a dynamic and evolving landscape, shaped by continuous advancements in technology and patient needs. Insulin sensitivity factors play a crucial role in optimizing insulin delivery, ensuring effective blood glucose control. Infusion site infections and cannula insertion techniques are key considerations, with ongoing research focusing on minimizing infection risks and improving insertion methods. Basal insulin rates are a critical aspect of insulin pump usage, requiring careful calibration to maintain optimal glucose levels. Mobile app integration and glucose monitoring sensors enable real-time data logging and analysis, enhancing user experience and improving hypoglycemia management. Tubing management and pump occlusion detection systems are essential safety features, preventing complications and ensuring reliable insulin delivery.
- Hyperglycemia management and alarm system settings are also vital components, offering users customized alerts and notifications to maintain glycemic control. Disposable components, such as insulin pump reservoirs and infusion sets, are subject to continuous innovation, with manufacturers focusing on enhancing durability and reducing waste. Closed-loop insulin systems, user interface designs, and hypoglycemia prevention strategies are among the latest developments, aiming to improve patient safety and overall effectiveness. Data logging capabilities, site rotation guidelines, bolus insulin calculators, and software updates are essential features that facilitate user convenience and streamline insulin delivery processes. Continuous glucose monitors, insulin delivery systems, and glycemic control algorithms are integral components of modern insulin pumps, offering advanced capabilities for blood glucose control.
- Remote monitoring features and wireless connectivity enable healthcare providers to closely monitor patients' insulin therapy, ensuring optimal treatment plans and timely interventions. Artificial pancreas technology represents the future of insulin pump innovation, offering automated insulin delivery and improved glucose control for better patient outcomes.
What are the Key Data Covered in this Insulin Pump Market Research and Growth Report?
-
What is the expected growth of the Insulin Pump Market between 2024 and 2028?
-
What segmentation does the market report cover?
-
The report segmented by Type (Tethered pumps and Patch pumps), Distribution Channel (Offline and Online), Geography (North America, Europe, Asia, and Rest of World (ROW)), Product Type (MiniMed Series, Accu-Chek Series, Tandem t:slim Series, Omnipod System, MyLife YpsoPump, and Others), and End-use (Hospitals & Clinics, Homecare Settings, and Laboratories)
-
Which regions are analyzed in the report?
-
What are the key growth drivers and market challenges?
-
Who are the major players in the Insulin Pump Market?
-
Key Companies AgVa Healthcare, Animas Corporation (a Medtronic subsidiary), Asante Solutions, Inc., Beta Bionics, Cellnovo Ltd., DexCom, Inc., F. Hoffmann-La Roche AG, Insulet Corporation, Johnson & Johnson, Lilly Diabetes (Eli Lilly and Company), MannKind Corporation, Medtronic plc, Microtech Medical Ltd., Modular Medical, Novo Nordisk A/S, Senseonics Holdings, Inc., SOOIL Development Co., Ltd., Tandem Diabetes Care, Inc., Terumo Corporation, and Valeritas, Inc.
Market Research Insights
- The market encompasses a diverse range of technologies designed to improve blood sugar regulation for individuals with diabetes. According to industry estimates, the market size reached approximately 11 billion USD in 2020, with a projected growth rate of 7% annually. One key factor driving market expansion is the integration of advanced features such as CGM data interpretation, patient safety protocols, and alarm customization. These innovations contribute to hyperglycemia reduction and enhanced insulin sensitivity testing, improving overall patient outcomes. In contrast, traditional insulin delivery methods, which require tubing priming, site care instructions, and carb counting strategies, account for a smaller market share.
- As technology advances, insulin pumps now offer features like basal rate adjustments, data management systems, and reservoir filling processes, ensuring a seamless user experience. Additionally, glucose sensor technology, occlusion detection alarms, and artificial pancreas benefits have emerged as significant market differentiators. With the advent of closed-loop algorithms, cannula insertion steps have become simpler, and Bluetooth compatibility and remote monitoring benefits have expanded accessibility. Pump maintenance, supply management, and site rotation schedules continue to evolve, ensuring optimal patient safety and convenience.
We can help! Our analysts can customize this insulin pump market research report to meet your requirements.
Get in touch
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 2.2 Market characteristics
- Market characteristics analysis
3 Market Sizing
- 3.1 Market definition
- Offerings of companies included in the market definition
- 3.2 Market segment analysis
- 3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
- 4.1 Global Insulin Pump Market 2018 - 2022
- Historic Market Size - Data Table on Global Insulin Pump Market 2018 - 2022 ($ million)
- 4.2 Type segment analysis 2018 - 2022
- Historic Market Size - Type Segment 2018 - 2022 ($ million)
- 4.3 Distribution Channel segment analysis 2018 - 2022
- Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ million)
- 4.4 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
- 4.5 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
- 5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
- 5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
- 5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
- 5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
- 5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
- 5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Type
- 6.1 Market segments
- Chart on Type - Market share (2023-2028) (%)
- Data Table on Type - Market share (2023-2028) (%)
- 6.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
- 6.3 Tethered pumps - Market size and forecast (2023-2028)
- Chart on Tethered pumps - Market size and forecast (2023-2028) ($ million)
- Data Table on Tethered pumps - Market size and forecast (2023-2028) ($ million)
- Chart on Tethered pumps - Year-over-year growth (2023-2028) (%)
- Data Table on Tethered pumps - Year-over-year growth (2023-2028) (%)
- 6.4 Patch pumps - Market size and forecast (2023-2028)
- Chart on Patch pumps - Market size and forecast (2023-2028) ($ million)
- Data Table on Patch pumps - Market size and forecast (2023-2028) ($ million)
- Chart on Patch pumps - Year-over-year growth (2023-2028) (%)
- Data Table on Patch pumps - Year-over-year growth (2023-2028) (%)
- 6.5 Market opportunity by Type
- Market opportunity by Type ($ million)
- Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Distribution Channel
- 7.1 Market segments
- Chart on Distribution Channel - Market share (2023-2028) (%)
- Data Table on Distribution Channel - Market share (2023-2028) (%)
- 7.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- 7.3 Offline - Market size and forecast (2023-2028)
- Chart on Offline - Market size and forecast (2023-2028) ($ million)
- Data Table on Offline - Market size and forecast (2023-2028) ($ million)
- Chart on Offline - Year-over-year growth (2023-2028) (%)
- Data Table on Offline - Year-over-year growth (2023-2028) (%)
- 7.4 Online - Market size and forecast (2023-2028)
- Chart on Online - Market size and forecast (2023-2028) ($ million)
- Data Table on Online - Market size and forecast (2023-2028) ($ million)
- Chart on Online - Year-over-year growth (2023-2028) (%)
- Data Table on Online - Year-over-year growth (2023-2028) (%)
- 7.5 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
8 Market Segmentation by Product Type
- 8.1 Market segments
- Chart on Product Type - Market share (2023-2028) (%)
- Data Table on Product Type - Market share (2023-2028) (%)
- 8.2 Comparison by Product Type
- Chart on Comparison by Product Type
- Data Table on Comparison by Product Type
- 8.3 MiniMed Series - Market size and forecast (2023-2028)
- Chart on MiniMed Series - Market size and forecast (2023-2028) ($ million)
- Data Table on MiniMed Series - Market size and forecast (2023-2028) ($ million)
- Chart on MiniMed Series - Year-over-year growth (2023-2028) (%)
- Data Table on MiniMed Series - Year-over-year growth (2023-2028) (%)
- 8.4 Accu-Chek Series - Market size and forecast (2023-2028)
- Chart on Accu-Chek Series - Market size and forecast (2023-2028) ($ million)
- Data Table on Accu-Chek Series - Market size and forecast (2023-2028) ($ million)
- Chart on Accu-Chek Series - Year-over-year growth (2023-2028) (%)
- Data Table on Accu-Chek Series - Year-over-year growth (2023-2028) (%)
- 8.5 Tandem t:slim Series - Market size and forecast (2023-2028)
- Chart on Tandem t:slim Series - Market size and forecast (2023-2028) ($ million)
- Data Table on Tandem t:slim Series - Market size and forecast (2023-2028) ($ million)
- Chart on Tandem t:slim Series - Year-over-year growth (2023-2028) (%)
- Data Table on Tandem t:slim Series - Year-over-year growth (2023-2028) (%)
- 8.6 Omnipod System - Market size and forecast (2023-2028)
- Chart on Omnipod System - Market size and forecast (2023-2028) ($ million)
- Data Table on Omnipod System - Market size and forecast (2023-2028) ($ million)
- Chart on Omnipod System - Year-over-year growth (2023-2028) (%)
- Data Table on Omnipod System - Year-over-year growth (2023-2028) (%)
- 8.7 MyLife YpsoPump - Market size and forecast (2023-2028)
- Chart on MyLife YpsoPump - Market size and forecast (2023-2028) ($ million)
- Data Table on MyLife YpsoPump - Market size and forecast (2023-2028) ($ million)
- Chart on MyLife YpsoPump - Year-over-year growth (2023-2028) (%)
- Data Table on MyLife YpsoPump - Year-over-year growth (2023-2028) (%)
- 8.8 Others - Market size and forecast (2023-2028)
- Chart on Others - Market size and forecast (2023-2028) ($ million)
- Data Table on Others - Market size and forecast (2023-2028) ($ million)
- Chart on Others - Year-over-year growth (2023-2028) (%)
- Data Table on Others - Year-over-year growth (2023-2028) (%)
- 8.9 Market opportunity by Product Type
- Market opportunity by Product Type ($ million)
- Data Table on Market opportunity by Product Type ($ million)
9 Market Segmentation by End-use
- 9.1 Market segments
- Chart on End-use - Market share (2023-2028) (%)
- Data Table on End-use - Market share (2023-2028) (%)
- 9.2 Comparison by End-use
- Chart on Comparison by End-use
- Data Table on Comparison by End-use
- 9.3 Hospitals & Clinics - Market size and forecast (2023-2028)
- Chart on Hospitals & Clinics - Market size and forecast (2023-2028) ($ million)
- Data Table on Hospitals & Clinics - Market size and forecast (2023-2028) ($ million)
- Chart on Hospitals & Clinics - Year-over-year growth (2023-2028) (%)
- Data Table on Hospitals & Clinics - Year-over-year growth (2023-2028) (%)
- 9.4 Homecare Settings - Market size and forecast (2023-2028)
- Chart on Homecare Settings - Market size and forecast (2023-2028) ($ million)
- Data Table on Homecare Settings - Market size and forecast (2023-2028) ($ million)
- Chart on Homecare Settings - Year-over-year growth (2023-2028) (%)
- Data Table on Homecare Settings - Year-over-year growth (2023-2028) (%)
- 9.5 Laboratories - Market size and forecast (2023-2028)
- Chart on Laboratories - Market size and forecast (2023-2028) ($ million)
- Data Table on Laboratories - Market size and forecast (2023-2028) ($ million)
- Chart on Laboratories - Year-over-year growth (2023-2028) (%)
- Data Table on Laboratories - Year-over-year growth (2023-2028) (%)
- 9.6 Market opportunity by End-use
- Market opportunity by End-use ($ million)
- Data Table on Market opportunity by End-use ($ million)
10 Customer Landscape
- 10.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
11 Geographic Landscape
- 11.1 Geographic segmentation
- Chart on Market share by geography 2023-2028 (%)
- Data Table on Market share by geography 2023-2028 (%)
- 11.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 11.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
- 11.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
- 11.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
- 11.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- 11.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
- 11.8 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
- 11.9 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
- 11.10 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
- 11.11 Japan - Market size and forecast 2023-2028
- Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Chart on Japan - Year-over-year growth 2023-2028 (%)
- Data Table on Japan - Year-over-year growth 2023-2028 (%)
- 11.12 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
- 11.13 Canada - Market size and forecast (2023-2028)
- Chart on Canada - Market size and forecast (2023-2028) ($ million)
- Data Table on Canada - Market size and forecast (2023-2028) ($ million)
- Chart on Canada - Year-over-year growth (2023-2028) (%)
- Data Table on Canada - Year-over-year growth (2023-2028) (%)
- 11.14 Italy - Market size and forecast (2023-2028)
- Chart on Italy - Market size and forecast (2023-2028) ($ million)
- Data Table on Italy - Market size and forecast (2023-2028) ($ million)
- Chart on Italy - Year-over-year growth (2023-2028) (%)
- Data Table on Italy - Year-over-year growth (2023-2028) (%)
- 11.15 France - Market size and forecast (2023-2028)
- Chart on France - Market size and forecast (2023-2028) ($ million)
- Data Table on France - Market size and forecast (2023-2028) ($ million)
- Chart on France - Year-over-year growth (2023-2028) (%)
- Data Table on France - Year-over-year growth (2023-2028) (%)
- 11.16 India - Market size and forecast (2023-2028)
- Chart on India - Market size and forecast (2023-2028) ($ million)
- Data Table on India - Market size and forecast (2023-2028) ($ million)
- Chart on India - Year-over-year growth (2023-2028) (%)
- Data Table on India - Year-over-year growth (2023-2028) (%)
- 11.17 Brazil - Market size and forecast (2023-2028)
- Chart on Brazil - Market size and forecast (2023-2028) ($ million)
- Data Table on Brazil - Market size and forecast (2023-2028) ($ million)
- Chart on Brazil - Year-over-year growth (2023-2028) (%)
- Data Table on Brazil - Year-over-year growth (2023-2028) (%)
- 11.18 Egypt - Market size and forecast (2023-2028)
- Chart on Egypt - Market size and forecast (2023-2028) ($ million)
- Data Table on Egypt - Market size and forecast (2023-2028) ($ million)
- Chart on Egypt - Year-over-year growth (2023-2028) (%)
- Data Table on Egypt - Year-over-year growth (2023-2028) (%)
- 11.19 UAE - Market size and forecast (2023-2028)
- Chart on UAE - Market size and forecast (2023-2028) ($ million)
- Data Table on UAE - Market size and forecast (2023-2028) ($ million)
- Chart on UAE - Year-over-year growth (2023-2028) (%)
- Data Table on UAE - Year-over-year growth (2023-2028) (%)
- 11.20 Oman - Market size and forecast (2023-2028)
- Chart on Oman - Market size and forecast (2023-2028) ($ million)
- Data Table on Oman - Market size and forecast (2023-2028) ($ million)
- Chart on Oman - Year-over-year growth (2023-2028) (%)
- Data Table on Oman - Year-over-year growth (2023-2028) (%)
- 11.21 Argentina - Market size and forecast (2023-2028)
- Chart on Argentina - Market size and forecast (2023-2028) ($ million)
- Data Table on Argentina - Market size and forecast (2023-2028) ($ million)
- Chart on Argentina - Year-over-year growth (2023-2028) (%)
- Data Table on Argentina - Year-over-year growth (2023-2028) (%)
- 11.22 KSA - Market size and forecast (2023-2028)
- Chart on KSA - Market size and forecast (2023-2028) ($ million)
- Data Table on KSA - Market size and forecast (2023-2028) ($ million)
- Chart on KSA - Year-over-year growth (2023-2028) (%)
- Data Table on KSA - Year-over-year growth (2023-2028) (%)
12 Drivers, Challenges, and Opportunity/Restraints
- 12.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
- 12.4 Market opportunities/restraints
13 Competitive Landscape
- 13.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 13.3 Landscape disruption
- Overview on factors of disruption
- 13.4 Industry risks
- Impact of key risks on business
14 Competitive Analysis
- 14.2 Market positioning of companies
- Matrix on companies position and classification
- 14.3 AgVa Healthcare
- AgVa Healthcare - Overview
- AgVa Healthcare - Product / Service
- AgVa Healthcare - Key offerings
- 14.4 Animas Corporation (a Medtronic subsidiary)
- Animas Corporation (a Medtronic subsidiary) - Overview
- Animas Corporation (a Medtronic subsidiary) - Product / Service
- Animas Corporation (a Medtronic subsidiary) - Key offerings
- 14.5 Asante Solutions, Inc.
- Asante Solutions, Inc. - Overview
- Asante Solutions, Inc. - Product / Service
- Asante Solutions, Inc. - Key offerings
- 14.6 Beta Bionics
- Beta Bionics - Overview
- Beta Bionics - Product / Service
- Beta Bionics - Key offerings
- 14.7 Cellnovo Ltd.
- Cellnovo Ltd. - Overview
- Cellnovo Ltd. - Product / Service
- Cellnovo Ltd. - Key offerings
- 14.8 DexCom, Inc.
- DexCom, Inc. - Overview
- DexCom, Inc. - Product / Service
- DexCom, Inc. - Key offerings
- 14.9 F. Hoffmann-La Roche AG
- F. Hoffmann-La Roche AG - Overview
- F. Hoffmann-La Roche AG - Product / Service
- F. Hoffmann-La Roche AG - Key offerings
- 14.10 Insulet Corporation
- Insulet Corporation - Overview
- Insulet Corporation - Product / Service
- Insulet Corporation - Key offerings
- 14.11 Johnson & Johnson
- Johnson & Johnson - Overview
- Johnson & Johnson - Product / Service
- Johnson & Johnson - Key offerings
- 14.12 Lilly Diabetes (Eli Lilly and Company)
- Lilly Diabetes (Eli Lilly and Company) - Overview
- Lilly Diabetes (Eli Lilly and Company) - Product / Service
- Lilly Diabetes (Eli Lilly and Company) - Key offerings
- 14.13 MannKind Corporation
- MannKind Corporation - Overview
- MannKind Corporation - Product / Service
- MannKind Corporation - Key offerings
- 14.14 Medtronic plc
- Medtronic plc - Overview
- Medtronic plc - Product / Service
- Medtronic plc - Key offerings
- 14.15 Microtech Medical Ltd.
- Microtech Medical Ltd. - Overview
- Microtech Medical Ltd. - Product / Service
- Microtech Medical Ltd. - Key offerings
- 14.16 Modular Medical
- Modular Medical - Overview
- Modular Medical - Product / Service
- Modular Medical - Key offerings
- 14.17 Novo Nordisk A/S
- Novo Nordisk A/S - Overview
- Novo Nordisk A/S - Product / Service
- Novo Nordisk A/S - Key offerings
- 14.18 Senseonics Holdings, Inc.
- Senseonics Holdings, Inc. - Overview
- Senseonics Holdings, Inc. - Product / Service
- Senseonics Holdings, Inc. - Key offerings
- 14.19 SOOIL Development Co., Ltd.
- SOOIL Development Co., Ltd. - Overview
- SOOIL Development Co., Ltd. - Product / Service
- SOOIL Development Co., Ltd. - Key offerings
- 14.20 Tandem Diabetes Care, Inc.
- Tandem Diabetes Care, Inc. - Overview
- Tandem Diabetes Care, Inc. - Product / Service
- Tandem Diabetes Care, Inc. - Key offerings
- 14.21 Terumo Corporation
- Terumo Corporation - Overview
- Terumo Corporation - Product / Service
- Terumo Corporation - Key offerings
- 14.22 Valeritas, Inc.
- Valeritas, Inc. - Overview
- Valeritas, Inc. - Product / Service
- Valeritas, Inc. - Key offerings
- 14.23 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Product / Service
- Abbott Laboratories - Key offerings
- 14.24 B.Braun SE
- B.Braun SE - Overview
- B.Braun SE - Product / Service
- B.Braun SE - Key offerings
- 14.25 Beta Bionics Inc.
- Beta Bionics Inc. - Overview
- Beta Bionics Inc. - Product / Service
- Beta Bionics Inc. - Key offerings
- 14.26 CeQur SA
- CeQur SA - Overview
- CeQur SA - Product / Service
- CeQur SA - Key offerings
- 14.27 ConvaTec Group Plc
- ConvaTec Group Plc - Overview
- ConvaTec Group Plc - Product / Service
- ConvaTec Group Plc - Key offerings
- 14.28 Dexcom Inc.
- Dexcom Inc. - Overview
- Dexcom Inc. - Product / Service
- Dexcom Inc. - Key offerings
- 14.29 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key offerings
- 14.30 Eoflow Co. Ltd.
- Eoflow Co. Ltd. - Overview
- Eoflow Co. Ltd. - Product / Service
- Eoflow Co. Ltd. - Key offerings
- 14.31 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Product / Service
- F. Hoffmann La Roche Ltd. - Key offerings
- 14.32 Insulet Corp.
- Insulet Corp. - Overview
- Insulet Corp. - Product / Service
- Insulet Corp. - Key offerings
- 14.33 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Product / Service
- Johnson and Johnson Services Inc. - Key offerings
- 14.34 MannKind Corp.
- MannKind Corp. - Overview
- MannKind Corp. - Product / Service
- MannKind Corp. - Key offerings
- 14.35 Medtronic PLC
- Medtronic PLC - Overview
- Medtronic PLC - Product / Service
- Medtronic PLC - Key offerings
- 14.36 Nipro Corp.
- Nipro Corp. - Overview
- Nipro Corp. - Product / Service
- Nipro Corp. - Key offerings
- 14.37 Nova Biomedical Corp.
- Nova Biomedical Corp. - Overview
- Nova Biomedical Corp. - Product / Service
- Nova Biomedical Corp. - Key offerings
- 14.38 Novo Nordisk AS
- Novo Nordisk AS - Overview
- Novo Nordisk AS - Product / Service
- Novo Nordisk AS - Key offerings
- 14.39 Senseonics Holdings Inc.
- Senseonics Holdings Inc. - Overview
- Senseonics Holdings Inc. - Product / Service
- Senseonics Holdings Inc. - Key offerings
- 14.40 SOOIL Development Co. Ltd.
- SOOIL Development Co. Ltd. - Overview
- SOOIL Development Co. Ltd. - Product / Service
- SOOIL Development Co. Ltd. - Key offerings
- 14.41 Tandem Diabetes Care Inc.
- Tandem Diabetes Care Inc. - Overview
- Tandem Diabetes Care Inc. - Product / Service
- Tandem Diabetes Care Inc. - Key offerings
- 14.42 Ypsomed Holding AG
- Ypsomed Holding AG - Overview
- Ypsomed Holding AG - Product / Service
- Ypsomed Holding AG - Key offerings
15 Appendix
- 15.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 15.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 15.4 Research methodology
- 15.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 15.9 360 degree market analysis
- 360 degree market analysis
- 15.10 List of abbreviations
INFORMATION SOURCES
DATA ANALYSIS
REPORT WRITING
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
